ELAN Elanco Animal Health Inc

Price (delayed)

$13.26

Market cap

$6.55B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.65

Enterprise value

$11.97B

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, ...

Highlights
The quick ratio has grown by 16% YoY and by 5% from the previous quarter
The debt is down by 4.2% year-on-year
ELAN's equity is down by 19% YoY and by 2.7% from the previous quarter
Elanco Animal Health's net income has decreased by 6% from the previous quarter

Key stats

What are the main financial stats of ELAN
Market
Shares outstanding
494.18M
Market cap
$6.55B
Enterprise value
$11.97B
Valuations
Price to book (P/B)
1.08
Price to sales (P/S)
1.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.74
Earnings
Revenue
$4.37B
EBIT
-$1.01B
EBITDA
-$325M
Free cash flow
$344M
Per share
EPS
-$2.65
Free cash flow per share
$0.7
Book value per share
$12.28
Revenue per share
$8.85
TBVPS
$10.84
Balance sheet
Total assets
$14.02B
Total liabilities
$7.96B
Debt
$5.77B
Equity
$6.06B
Working capital
$2.82B
Liquidity
Debt to equity
0.95
Current ratio
3.29
Quick ratio
1.16
Net debt/EBITDA
-16.68
Margins
EBITDA margin
-7.4%
Gross margin
55.3%
Net margin
-29.8%
Operating margin
-23.2%
Efficiency
Return on assets
-8.9%
Return on equity
-20.2%
Return on invested capital
-10.9%
Return on capital employed
-7.9%
Return on sales
-23.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ELAN stock price

How has the Elanco Animal Health stock price performed over time
Intraday
3.59%
1 week
0.08%
1 month
-26.54%
1 year
10.32%
YTD
-11.01%
QTD
-8.11%

Financial performance

How have Elanco Animal Health's revenue and profit performed over time
Revenue
$4.37B
Gross profit
$2.41B
Operating income
-$1.01B
Net income
-$1.3B
Gross margin
55.3%
Net margin
-29.8%
The company's operating margin fell by 12% QoQ
Elanco Animal Health's operating income has decreased by 10% from the previous quarter
The net margin is down by 7% since the previous quarter
Elanco Animal Health's net income has decreased by 6% from the previous quarter

Growth

What is Elanco Animal Health's growth rate over time

Valuation

What is Elanco Animal Health stock price valuation
P/E
N/A
P/B
1.08
P/S
1.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.74
The company's EPS fell by 6% QoQ
The price to book (P/B) is 23% lower than the 5-year quarterly average of 1.4 but 8% higher than the last 4 quarters average of 1.0
ELAN's equity is down by 19% YoY and by 2.7% from the previous quarter
ELAN's P/S is 42% below its 5-year quarterly average of 2.6

Efficiency

How efficient is Elanco Animal Health business performance
Elanco Animal Health's ROE has decreased by 12% from the previous quarter
The company's return on sales fell by 12% QoQ
The company's return on assets fell by 9% QoQ
Elanco Animal Health's ROIC has decreased by 9% from the previous quarter

Dividends

What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELAN.

Financial health

How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 76% higher than its total liabilities
Elanco Animal Health's current ratio has increased by 46% YoY and by 20% from the previous quarter
The quick ratio has grown by 16% YoY and by 5% from the previous quarter
The debt is 4.8% smaller than the equity
The debt to equity has increased by 19% year-on-year and by 2.2% since the previous quarter
ELAN's equity is down by 19% YoY and by 2.7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.